GD2 suppresses DC antigen presentation and the expression of MHC-I and MHC-II molecules, rendering neuroblastoma tumor cells invisible to cytotoxic CD8+ T lymphocytes, and repressing the ability of CD4+ helper T lymphocytes to mount an immune response via cytokine signaling inhibition [12,36]. This evidence concerns the gene CD8A and neoplasm.